Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$3.97 -0.03 (-0.75%)
At close: Nov 10, 2026 · 4:00 PM EST

Oramed Pharmaceuticals (ORMP) EV to CFO (2010 - 2017)

Updated

Oramed Pharmaceuticals' (ORMP) EV to CFO stood at 34.35 in Q3 2017, up 43.6% from the prior quarter.

Analysis

Oramed Pharmaceuticals (ORMP) EV to CFO (2010 - 2017) Analysis & Trends

On a TTM basis, Oramed Pharmaceuticals' EV to CFO came in at 28.46 as of May 31, 2017; for FY2016, it was 18.97.

  • Per Business Quant, the preceding three quarters came in at 23.91 (Q2 2017), 8.99 (Q1 2017) and 18.97 (Q4 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Oramed Pharmaceuticals 164.02 Mn -170.72 Mn -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2017 34.35
Feb 28, 2017 23.91
Nov 30, 2016 8.99
Aug 31, 2016 18.97
Nov 30, 2010 0.10
API Access

Oramed Pharmaceuticals EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ORMP&period=max&api_key=YOUR_API_KEY